Delivery hemorrhage: Management in France, and interest of prostaglandins;HEMORRAGIES DE LA DELIVRANCE: PRISE EN CHARGE EN FRANCE ET INTERET DES PROSTAGLANDINES

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 26, Issue SUPPL. 2, 1997, Pages 26-33

  Goffinet, F ^a  

^a Groupe Hospitalier Cochin ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

OXYTOCIN; PROSTAGLANDIN; PROSTAGLANDIN E2; SULPROSTONE; OXYTOCIC AGENT;

BLEEDING; CONFERENCE PAPER; DRUG EFFICACY; FEMALE; FETUS; FRANCE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LABOR; NEWBORN; POSTPARTUM HEMORRHAGE; TOCOLYSIS; VAGINAL DELIVERY; INCIDENCE; LABOR COMPLICATION; PREGNANCY; REVIEW; UTERUS BLEEDING;

FEMALE; FRANCE; HUMANS; INCIDENCE; OBSTETRIC LABOR COMPLICATIONS; OXYTOCICS; PREGNANCY; PROSTAGLANDINS; UTERINE HEMORRHAGE;

EID: 0030768993     PISSN: 03682315     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (45)

1. Newton M, Mosey LM, Eggli GE, Glfford WB, Hull CT. Blood loss during and immediately after delivery. Obstet Gynecol 1961;17:9-18.
2. Wallace G. Blood loss in obstetrics using a haemoglobin dilution technique. J Obstet Gynaecol Br Commonw 1967;74:64-67.
3. Hall M, Halliwell R, Carrhill R. Concomitant and repeated happenings of complications of the third stage of labour. Br J Obstet Gynaecol 1985;92:732-738.
4. Robson SC, Boys RJ, Hunter S et al. Maternal hemodynamics after normal delivery and delivery complicated by post-partum hemorrhage. Obstet Gynecol, 1989;74:234-239.
5. Racinet C, Berthet J. Délivrance normale et pathologique. Encycl Med Chir Obstétrique 1982;5108,M10:10-14.
6. Bouvier-Colle MH, Varnoux N, Costes PH et al. Mortalité maternelle en France. Fréquence de sa sous-estimation dans la statistique des causes médicales de décès. J Gynecol Obstet Biol Reprod 1991;20:885-891.
7. Magnin P, Nicollet B, Magnin G. La mortalité maternelle. Encycl Med Chir, Paris Obstétrique 1981;5082:D10.
8. Bouvier-Colle MH, Varnoux N, Bréart G. Les morts maternelles en France, 1994.
9. El Kady AA, Sale HS, Gadalla S, Fortney J, Bayoumi H. Obstetric deaths in Menoufia Governorate Egypt. Br J Obstet Gynecol 1989;96:9-14.
10. Harrison KA. Maternal mortality in developing countries. Br J Obstet Gynaecol 1986;96:1-3.
11. Bouvier-Colle MH, Salanave B, Ancel PY et al. Obstetric patients treated in intensive care units and maternal mortality. Eur J Obstet Gynecol Reprod Biol 1996;65:121-5.
12. ACOG Technical bulletin number 143, July 1990. Diagnosis and management of post-poartum hemorrhage. Int J Gynecol Obstet 1991;36:159-63.
13. Hemmiki E, Merilainen J. Long-term follow-up of mothers and their infants in a randomized trial on iron prophylaxis during pregnancy. Am J Obstet Gynecol 1995;173:205-9.
14. Coombs CA, Murphy EL, Laros RK. Factors associated with post-partum hemorrhage with vaginal birth. Obstet Gynecol 1991;77:69-76.
15. Gilbert L, Porter W, Brown VA. Post-partum hemorrhage: a continuing problem. Br J Obstet Gynaecol 1987;94:67-71.
16. Prendiville W, Elbourne D, Chalmers I. The effects of routine oxytocic administration in the management of the third stage of labour : an overview of the evidence from controlled trials. Br J Obstet Gynaecol 1988;95:3-16.
17. Pierre F. Peut-on réduire la spoliation sanguine liée à l'accouchement? Presse Med 1990;44:2012-2014.
18. Elbourne D, Prendiville W, Chalmers I. Choice of oxytocic preparation for routine use in the management of the third stage of labour : on overview of the evidence from controlled trials. Br J Obstet Gynaecol 1988;95:17-30.
19. Thomas IC, Jeffers TM, Brazier JM et al. Does cord drainage of placental bolld facilitate delivery of the placenta ? Aust NZ J Obstet Gynecol 1990;30:314-318.
20. Dewhurst J. The prevention of post partum haemorrhage : a review. J Obstetr Gynaecol 1990;10:51-53.
21. Carrel T, Carrel B, Jutzi H et al. Occlusion artérielle aiguë d'origine médicamenteuse, helv Chir Acta 1990;57: 169-175.
22. Hammar M, Bostrom K, Borvrall B. Comparison between the influence of methylergometrine and oxytocin on the incidence of retained placenta in the third stage of labour. Gynec Obstet Invest 1990;30:91-93.
23. Halle H, Hengst P. Der einsatz von PGF2-α in der nachgeburtsperiod. Zentralbl Gynäkol 1979;101:916-17.
24. Van Dongen PWJ, Van Roosmalen J, Boer CN et al. Oxytocis for prevention of post partum hemorrhage. Pharmaceutisch Weekblood Scientific Edition 1991;13:238-243.
25. Kerekes L, Domokos L. The effect of prostaglandin F2-α on third stage labor. Prostaglandins 1979;18:161-166.
26. Moir JC. The action of ergot preparations on the puerperal uterus. Br Med J 1932;i:1119-122.
27. Moir JC. The obstetrician bids and the uterus contracts. Br Med J 1964;ii:1025-29.
28. Beuthe D. Die beeinflussung der nachgeburtsperiode durch methergin. Zbl Gynak 1956;78:1305-14.
29. Fuchs AR, Husslein P, Sumalon GL et al. The origin of circulating 13, 14-dihydro-15-keto-prostaglandin F2 a during delivery. Prostaglandins 1982;24:715-722.
30. Keirse MJNC. Biosynthesis and metabolism of prostaglandins within the human uterus in early end late prengancy. In : Wood C (ed). The role of prostaglandins in labour. London : Royal Society of Médecine 1985:25-38.
31. Sellers SM, Hodgson HT, Mitchel MD et al. Raised prostaglandin levels in the third stage of labor. Am J Obstet Gynecol 1982;144:209-212.
32. Bygdeman M, Kwonsu T, Mukkerhee T, Wiqvist N. Effect of infusion of PGE1 and PGE2 on the motility of the pregnant human uterus. Am J Obstet Gynecol 1968;129:918-919.
33. Baumgarten K. Uterine motility after post-partum application of sulprostone and oxytocis. Europ J Obstet Gynec Reprod Biol 1983;16:181-192?
34. Tagaki S, Yoshida T, Togo Y. The effects of intra-myometrial injection of prostaglandin F2 a on severe post partum hemorrhage. Prostaglandins 1976:12:565-579.
35. Bigrigg A, Chui D, Chissel S et al. Use of intramyometrial 15-methyl prostaglandin F2 a to control atonic post-partum hemorrhage following vaginal delivery and failure of conventional therapy. Br J Obstet Gynaecol 1991;90:734.
36. Corson SL, Bolognese RJ. Post-partum uterine atony treated with prostaglandins. Am J Obstet Gynecol 1977;129:918-19.
37. Godicke HD. The treatment of post partum atonic haemorrhage with the prostaglandin nalador. Results of a multiœntre trial. Facultas-Universitasverlag Wien, 1989.
38. Hayashi RH, Castillo MS, Noah ML. Management of severe post-partum hemorrhage with prostaglandin F2-α analogue. Obstet Gynecol 1984;63:806-808.
39. Thiery M. Prostaglandins for post-paryum hemorrhage. In : Keirse MJNC, de Koning Gans HJ (eds). Priming and induction of labour by prostaglandins : a state of the art. Leiden : Boerhaave committe for postgraduate medical education 1987:89-104.
40. Toppozada M, El-Bossaty M, El-Rahman HA, Shams El-Din MH. Control of intractable atonic postpartum hemorrhage by 15-methyl prostaglandin F2-α. Obstet Gynecol 1981;58:327-330.
41. Hess HJ, Schaaf TK, Bindra JS, Johonson MR, Constantine JW. Structure-activity considerations leading to sulprostone. In international sulprostone symposium, Vienne, Schering AG, Berlin 1978:29-37.
42. Delay M, Genestal M, Carrie M, Livarek B, Boudjemaa B, Bernardet P. Arrêt cardio-circulatoire après administration de l'association mifépristone (Mifégyne) sulprostone (Nalador) pour interruption de grossesse. Arch Mal Cœur 1992;85:105-7.
43. Spona J, Baumgarten K, Schmidt J, Gruber W, Godicke HD, Grunberger W. 13,14-dihydro-15-keto-PGF2-α (PGFM) and sulprostone levels after application of sulprostone to post-partum women. Europ J Obstet Gynecol Reprod Biol 1983;16:173-79.
44. Goffinet F, Haddad B, Carbonne B, Sebban E, Papiernik E, Cabrol D. Utilisation pratique de la sulprostone dans le traitement des hémorragies de la délivrance. J Gynecol Obstet Biol Reprod 1995;24:209-16.
45. Van Selm M, Kanhai HHH, Keirse MJNC. Preventing the recurrence of atonic post-partum hemorrhage : a double-blind trial. Acta Obstet Gynecol Scand 1995;74:270-4.